Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial

BACKGROUND: There is concern that selective serotonin reuptake inhibitors (SSRIs) substantially increase bleeding risk in patients taking anticoagulants. METHODS AND RESULTS: We studied 737 patients taking SSRIs in the ROCKET AF (Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Am Heart Assoc
Главные авторы: Quinn, Gene R., Hellkamp, Anne S., Hankey, Graeme J., Becker, Richard C., Berkowitz, Scott D., Breithardt, Günter, Fava, Maurizio, Fox, Keith A. A., Halperin, Jonathan L., Mahaffey, Kenneth W., Nessel, Christopher C., Patel, Manesh R., Piccini, Jonathan P., Singer, Daniel E.
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2018
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201450/
https://ncbi.nlm.nih.gov/pubmed/30371223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.008755
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы